Skip to content
healthcare.dev

Gelusil

NDC 65197-300, Alumina, Magnesia, Simethicone, tablet, chewable, from WellSpring Pharmaceutical Corporation.

Product NDC
65197-300
Status
Listed
Labeler
WellSpring Pharmaceutical Corporation
Dosage form
TABLET, CHEWABLE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M001
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65197-300 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ALUMINUM HYDROXIDE200 mg/1
  • MAGNESIUM HYDROXIDE200 mg/1
  • DIMETHICONE, UNSPECIFIED24 mg/1
  • SILICON DIOXIDE1 mg/1

Pharmacologic classes

Calculi Dissolution Agent [EPC]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Skin Barrier Activity [PE]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Package NDCNDC-11Package
65197-300-106519703001010 BLISTER PACK in 1 CARTON (65197-300-10) / 10 TABLET, CHEWABLE in 1 BLISTER PACK
65197-300-1165197030011100 TABLET, CHEWABLE in 1 BOTTLE (65197-300-11)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 65197-300 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65197-300 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65197-300. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.